Consumer Discretionary

1933 Industries Reports Third Quarter Financial Results for Fiscal 2026

Last Updated:
Reading Time
2 min

#Overview of Financial Performance

1933 Industries Inc., a cannabis cultivator and producer based in Nevada, has reported its financial results for the third quarter of fiscal 2026. The company delivered total revenue of CAD 12.2 million for the fiscal year, marking a decline from CAD 13.1 million in fiscal 2025. This decrease reflects the competitive landscape of the cannabis market in Nevada.

#Quarterly Revenue and Expenses

In the third quarter of 2026, the company achieved revenue of CAD 4.29 million, down from CAD 4.73 million in the same period last year. However, there was an 8.8% sequential increase from the second quarter of 2026, indicating a potential rebound.

Expenses for fiscal 2026 were CAD 3.12 million, representing a significant 45.6% decrease from CAD 5.74 million in the previous year. For Q3 2026, expenses dropped to CAD 962,303, a notable reduction from CAD 2.03 million recorded in Q3 2025. This expense reduction is attributed to effective cost management and operational efficiencies.

#Gross Profit and Margin

For the fiscal year, gross profit stood at CAD 3.28 million compared to CAD 5.32 million in fiscal 2025. The gross margin also experienced a decline, falling to 27% from 40% year-over-year. In Q3 2026, the gross margin was 31%, down from 53% in the prior year’s comparable period. These changes highlight ongoing pricing pressures and competition within the Nevada market.

#Net Income Reporting

1933 Industries reported a net income of CAD 154,092 in fiscal 2026, showing a substantial improvement from a net loss of CAD 418,803 in the previous year. The comprehensive income was CAD 86,427, significantly reversing from a comprehensive loss in fiscal 2025. This positive shift underscores the company's efficiency measures and indicates a move towards a sustainable operating model.

#Management Insights

Management expressed optimism regarding the company’s performance. Brian Farrell, Chairman and CEO, noted the improvement in profitability and emphasized the successful implementation of cost optimization initiatives. President Ester Vigil also highlighted a growing consumer preference for flower products, which supports the company’s market position.

#Future Expectations

Looking forward, 1933 Industries anticipates federal changes regarding the regulation of intoxicating hemp products, which could positively impact the Nevada cannabis market. The changes are expected to help stabilize and enhance competition within the sector. The company remains committed to further operational improvements and exploring growth opportunities.

#Key Takeaways

  • 1933 Industries reported CAD 12.2 million in revenue for fiscal 2026, down from CAD 13.1 million in fiscal 2025.
  • The company achieved a net income of CAD 154,092, a significant turnaround from the previous year’s loss.
  • Expenses declined by 45.6%, showcasing effective cost management measures.
  • Gross margin decreased to 27%, reflecting ongoing competition in the market.
  • Future regulatory changes related to hemp products may create a more favorable market environment for the company.

Original source: Read original article

Frequently Asked Questions

1933 Industries reported total revenues of $12,201,267 for fiscal 2026. Although this represents a decline from the previous fiscal year's revenues, the company has demonstrated resilience amid market challenges.
For fiscal 2026, 1933 Industries reported a net income of $154,092, a significant turnaround from a net loss of $418,803 in fiscal 2025. This improvement underscores effective cost management and operational efficiencies.
The company achieved a remarkable 45.6% reduction in expenses for fiscal 2026 compared to the prior year. Such disciplined cost controls suggest a strong focus on enhancing profitability.
The gross margin for fiscal 2026 was 27%, down from 40% in fiscal 2025, reflecting ongoing pricing pressures. Nevertheless, the company is actively managing costs and pricing strategies to support future growth.
The Company saw sequential revenue growth of 8.8% in Q3 2026, alongside significant cost reductions. This indicates a potential for sustained improvement and a strong brand presence in the competitive Nevada market.
The anticipated federal changes related to hemp regulation could positively impact the legal cannabis market in Nevada, potentially benefiting 1933 Industries by reducing competition from hemp-derived products.
1933 Industries, through its American Medical Association brand, offers a range of cannabis products including flower and concentrates, which consistently rank as top sellers in Nevada, highlighting their market popularity and consumer acceptance.
Given the company’s improved profitability and strategic focus on cost management, along with potential regulatory changes in the cannabis sector, there are encouraging signs for 1933 Industries' future performance and market position.